ALP-3 RT 20mg

Description

ALP-3 RT (Retatrutide) is a next-generation triple agonist peptide that simultaneously targets GLP-1, GIP, and glucagon receptors. This multi-receptor engagement makes it one of the most studied compounds in contemporary metabolic pathway research.

Each vial is supplied in lyophilized (freeze-dried) form, sealed under controlled conditions to preserve peptide integrity. Available in 10mg, 20mg, 30mg, and 60mg formats to accommodate varying research requirements.

Avade Labs sources ALP-3 RT from verified suppliers and subjects each batch to third-party laboratory testing through Janoshik Analytical. Certificate of Analysis (COA) results are available on our COA Library page.

This product is intended strictly for in vitro laboratory and research use only. It is not intended for human or animal consumption, therapeutic use, or any clinical application. For research purposes only.